Eric Dein ejdein1
Auckland-based rheumatologist Dr. Nicola Dalbeth discusses improving responses to the use of Pegloticase, including abstracts #0677 and #0952.
Dr. Gensler reviews her top selections for ACR 2020 today, including abstract #0881 and #0876. She also highlighted the study group on spondyloarthritis, which focused on nomenclature.
Dr. John Cush RheumNow
Dr. Mrinalini Dey interviews Dr. James Galloway on infection in rheumatic diseases, and the studies and presentations he's interested in on infection at the 2020 ACR annual meeting.
Dr. Kathryn Dao reviews abstract #0533 presented at the 2020 ACR annual meeting.
Dr. Mrinalini Dey reviews abstract #0934 presented Saturday at the 2020 ACR annual meeting.
Leonard Calabrese LCalabreseDO
Meral K. El Ramahi, MD MeralElRamahiMD
Portland-based Dr. Kevin Winthrop from OHSU discusses Saturday ACR 2020 posters #0623 and #0629 related to COVID-19 and RA patients.
Dr. Eric Dein reviews abstract #0481 presented at the 2020 ACR annual meeting, and reviews the Twitter poll he posted on whether clinicians would start DMARDs in this scenario.
Dr. John Cush RheumNow
Dr. John Cush RheumNow
Richard Conway RichardPAConway
NYU's Dr. Michael Pillinger promises deeper looks at ACR 2020 activity regarding gout, but starts out reporting data from GCAN.